New research suggests that many people who’ve undergone an organ transplant do not get an immune response from COVID-19 vaccines that’s strong enough to ward off a “breakthrough” infection. In a new review of 14 such cases, these breakthrough COVID-19 infections occurred in 10 recipients of new kidneys, two liver recipients, one lung recipient and… read on > read on >
The U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer’s disease in nearly two decades, in a controversial decision that left the agency defending its reputation and its science. Aduhelm (aducanumab) treats Alzheimer’s by clearing out amyloid beta, a sticky protein known to form plaques in the brains of early-stage… read on > read on >
That third or fourth cup of coffee may do more than make your heart race: New research suggests it could significantly increase your risk of glaucoma if you’re genetically predisposed to the eye disease. The study included more than 120,000 British people, aged 39 to 73, who provided information about their caffeine consumption and their… read on > read on >
Women whose diets tend to feed inflammation may have a heightened risk of breast cancer, a preliminary study suggests. The study, of more than 350,000 women, found that the more “pro-inflammatory” foods women consumed, the higher their breast cancer risk. The term refers to foods thought to contribute to chronic low-grade inflammation throughout the body… read on > read on >
The first new Alzheimer’s drug in nearly two decades was approved by the U.S. Food and Drug Administration on Monday, despite opposition from the agency’s own independent advisory committee and some experts who said there wasn’t enough proof the drug could actually help patients. In clinical trials, aducanumab (Aduhelm) showed a 22% reduction in the… read on > read on >
MONDAY, June 7, 2021 (American Heart Association News) — Nice weather and a receding pandemic should make for a joyous, memorable summer, especially after a year of lockdowns, frustration and discouraging news. For kids, and their parents, it’s also a chance to get back on the road to normal after a long COVID-19 detour. “I’m… read on > read on >
After being diagnosed with bladder cancer, some patients face an almost impossible decision — have their bladder removed or take a risk knowing that the cancer may be more likely to spread if the bladder is left intact. But what if there was another way? For David Cabelis, 68, the decision was more straightforward than… read on > read on >
People hospitalized for COVID-19 are often discharged in much worse shape than before their illness — underscoring the value of preventing severe cases with vaccination. In a new study, researchers found that during the pandemic’s early months, almost half of COVID-19 patients discharged from their health system had some degree of “functional decline.” That’s a… read on > read on >
Antibiotics do not reduce the risk of hospitalization or death in patients with a lethal lung disease known as idiopathic pulmonary fibrosis, a new study finds. “We were certainly disappointed in the results,” said study co-author Dr. Imre Noth, chief of pulmonary and critical care medicine at UVA Health in Charlottesville, Va. “But we remain… read on > read on >
It has been an elusive goal so far — finding a potent treatment that can beat back the new coronavirus before it grabs a hold of a patient’s immune system and sends it into overdrive. But new research suggests that more than a dozen existing drugs or drugs under development may do the trick. Investigators… read on > read on >
